Abbvie Inc ABBV-AT:Vienna Stock Exchange

*Data is delayed | EUR
Last | 4:04 PM CET
90.07quote price arrow up+2.07 (+2.35%)
Volume
117
52 week range
0.00 - 90.10

...

Loading . . .

KEY STATS

  • Open90.07
  • Day High90.10
  • Day Low90.07
  • Prev Close88.00
  • 52 Week High90.10
  • 52 Week High Date03/01/21
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap190,175.41M
  • Shares Out1,765.13M
  • 10 Day Average Volume-
  • Dividend4.30
  • Dividend Yield4.77%
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)2.22
  • P/E (TTM)40.57
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Abbvie Inc News

There is no recent news for this security.

Latest ABBV-AT News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's...
Richard Gonzalez
Chairman
Carlos Alban
Vice Chairman - Management
Laura Schumacher
Vice Chairman - Management
Michael Severino M.D.
President
Robert Michael
Chief Financial Officer
Henry Gosebruch
Executive Vice President
Address
1 N Waukegan Rd
North Chicago, IL
60064-1802
United States